The clinical impact and outcomes of immunohistochemistry-only metastases in breast cancer

被引：0
|
作者：
Pugliese, M. S. [1 ]
Stempel, M. M. [1 ]
Patil, S. M. [1 ]
Hsu, M. [1 ]
Cody, H. S., III [1 ]
Morrow, M. [1 ]
Gemignani, M. L. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
613
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Clinical impact of SPECT/CT bone scan in the assessment of bone metastases in breast cancer
    Han, Sai
    Colville, David
    Ainslie-McLaren, Gillian
    Lang, Jason
    Watt, Sara
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [32] Impact of insurance and socioeconomic status on clinical outcomes in therapeutic clinical trials for breast cancer
    Obeng-Gyasi, Samilia
    O'Neil, Anne
    Zhao, Fengmin
    Kircher, Sheetal M.
    Lava, Timsina R.
    Wagner, Lynne I.
    Miller, Kathy D.
    Sparano, Joseph A.
    Sledge, George W.
    Carlos, Ruth C.
    CANCER RESEARCH, 2020, 80 (04)
  • [33] Outcomes with Contralateral Axillary Nodal Metastases in Breast Cancer
    Sauder, C. A.
    Stauder, M.
    Hunt, K. K.
    Lucci, A.
    Mittendorf, E. A.
    Whitman, G. J.
    Kuerer, H. M.
    Caudle, A. S.
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S64 - S65
  • [34] ADVANCED BREAST-CANCER WITH BONE-ONLY METASTASES - A CHEMOTHERAPEUTICALLY RESPONSIVE PATTERN OF METASTASES
    SMALLEY, RV
    SCOGNA, DM
    MALMUD, LS
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1982, 5 (02): : 161 - 166
  • [35] Radiation therapy for bone-only metastases in breast cancer patients: A GOCO survey of current clinical practice
    Bonet, Marta
    Garcia, Virginia
    Farre, Nuria
    Algara, Manel
    Farrus, Blanca
    Fernandez, Jaume
    Reyes, Victoria
    Eraso, Arancha
    Alvarez, Ana
    Jose Cambra, Maria
    Pedro, Agusti
    Vayreda, Jordi
    Lemansky, Claire
    Izar, Francoise
    Arenas, Meritxell
    REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2020, 25 (01) : 113 - 116
  • [36] Differences of Clinical Manifestations and Therapeutic Outcomes in Leptomeningeal Metastases (LM) According to Breast Cancer Subtypes
    Lee, S.
    Nam, D. H.
    Lee, J. I.
    Park, W.
    Choi, D. H.
    Huh, S. J.
    Park, Y. H.
    Ahn, J. S.
    Im, Y-H.
    CANCER RESEARCH, 2010, 70
  • [37] Application of Immunohistochemistry in Clinical Practices as a Standardized Assay for Breast Cancer
    Masuda, Shinobu
    Nakanishi, Yoko
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 2023, 56 (01) : 1 - 8
  • [38] Inability of immunohistochemistry to predict clinical outcomes of endometrial cancer patients
    Gossett, DR
    Alo, P
    Bristow, RE
    Galati, M
    Kyshtoobayeva, A
    Fruehauf, J
    Montz, FJ
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2004, 14 (01) : 145 - 151
  • [39] Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomes
    A H Thomson
    J McGrane
    J Mathew
    J Palmer
    D A Hilton
    G Purvis
    R Jenkins
    British Journal of Cancer, 2016, 114 : 793 - 800
  • [40] Changing molecular profile of brain metastases compared with matched breast primary cancers and impact on clinical outcomes
    Chung, C.
    BREAST DISEASES, 2016, 27 (04): : 320 - 321
12345